Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 4/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 1.00 |
| ▸ | MAPT | P10636 | 3/20 | 1.00 |
| ▸ | TSHR | P16473 | 2/20 | 1.00 |
| ▸ | NFKB1 | P19838 | 2/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 2/20 | 1.00 |
| ▸ | HPGD | P15428 | 2/20 | 1.00 |
| ▸ | RGS12 | O14924 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | POLB | P06746 | 1/20 | 1.00 |
| ▸ | APEX1 | P27695 | 1/20 | 1.00 |
| ▸ | THPO | P40225 | 1/20 | 1.00 |
| ▸ | BLM | P54132 | 1/20 | 1.00 |
| ▸ | GNAI1 | P63096 | 1/20 | 1.00 |
| ▸ | PMP22 | Q01453 | 1/20 | 1.00 |
| ▸ | CA2 | P00918 | 3/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.61 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 3,4-Dihydroxyphenylacetic Acid SCHEMBL36348 | 1.00 | GAA (1.00) | GAAKDM4ETDP1HSD17B10MAPT | |
| 3,4-Dihydroxyphenylacetic Acid SCHEMBL8214151 | 0.98 | GAA (0.96) | GAAKDM4ETDP1HSD17B10MAPT | |
| 3,4-Dihydroxyphenylacetic Acid SCHEMBL8214147 | 0.98 | GAA (0.96) | GAAKDM4ETDP1HSD17B10MAPT | |
| 3,4-Dihydroxyphenylacetic Acid SCHEMBL18338957 | 0.92 | GAA (0.85) | GAAKDM4ETDP1HSD17B10MAPT | |
| 3,4-Dihydroxyphenylacetic Acid SCHEMBL21381267 | 0.92 | GAA (0.85) | GAAKDM4ETDP1HSD17B10MAPT | |
| 3,4-Dihydroxyphenylacetic Acid SCHEMBL175566 | 0.89 | TDP1 (0.79) | GAAKDM4ETDP1HSD17B10MAPT | |
| 3,4-Dihydroxyphenylacetic Acid SCHEMBL29246309 | 0.87 | GAA (0.76) | GAAKDM4ETDP1HSD17B10MAPT | |
| 3,4-Dihydroxyphenylacetic Acid SCHEMBL8565392 | 0.87 | GAA (0.76) | GAAKDM4ETDP1HSD17B10MAPT | |
| SCHEMBL2050404 | 0.84 | GAA (0.73) | GAAKDM4ETDP1HSD17B10MAPT | |
| SCHEMBL15499982 | 0.84 | GAA (0.73) | GAAKDM4ETDP1HSD17B10MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12636402-B2 | Chitosan dressing for control of gastrointestinal bleeding | TRICOL BIOMEDICAL, INC. (US) | 2026-05-26 | — | — | US | disclosed |
| EP-4181781-B1 | BREATH-BASED THERAPEUTIC DRUG MONITORING METHOD | UNIV KINDERSPITAL BEIDER BASEL (CH) | 2026-05-20 | — | — | EP | disclosed |
| US-12616771-B2 | Tissue adherent chitosan material that resists dissolution | TRICOL BIOMEDICAL, INC. (US) | 2026-05-05 | — | — | US | disclosed |
| US-12590065-B2 | Levorphanol prodrugs and processes for making and using them | ZEVRA THERAPEUTICS, INC. (US) | 2026-03-31 | — | — | US | disclosed |
| US-12508171-B2 | Delivery systems for control of bleeding in transurethral prostatectomy | TRICOL BIOMEDICAL, INC. (US) | 2025-12-30 | — | — | US | disclosed |
| EP-4630006-A1 | FLOWABLE CHITOSAN BIOADHESIVE HEMOSTATIC COMPOSITIONS THAT RESIST DISSOLUTION | Tricol Biomedical, Inc. (US) | 2025-10-15 | — | — | EP | disclosed |
| US-12365025-B2 | Fine metal linear body | MITSUI MINING & SMELTING CO., LTD. (JP) | 2025-07-22 | — | — | US | disclosed |
| US-12295394-B2 | Water-soluble additive composition | SUMITOMO BAKELITE CO., LTD. (JP) | 2025-05-13 | — | — | US | disclosed |
| US-12275975-B2 | Conversion of lignin into bioplastics and lipid fuels | The Texas A&MUniversity System (US) | 2025-04-15 | — | — | US | disclosed |
| WO-2025069904-A1 | PROCESSING LIQUID, METHOD FOR PROCESSING OBJECT TO BE PROCESSED, METHOD FOR PROCESSING PAD, AND METHOD FOR MANUFACTURING ELECTRONIC DEVICE | 富士フイルム株式会社 | 2025-04-03 | — | — | WO | disclosed |
| US-11564673-B2 | Delivery systems for control of gastrointestinal bleeding | TRICOL BIOMEDICAL, INC. (US) | 2023-01-31 | — | — | US | disclosed |
| WO-2022261201-A1 | DISSOLUTION RESISTANT TISSUE ADHERENT DRESSING APPLICATION AND ITS DELIVERY | TRICOL BIOMEDICAL, INC. (US) | 2022-12-15 | — | — | WO | disclosed |
| US-11519011-B2 | Conversion of lignin into bioplastics and lipid fuels | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2022-12-06 | — | — | US | disclosed |
| WO-2022122921-A1 | PROCESS FOR THE BIOTECHNOLOGICAL PRODUCTION OF 2-PHENYLETHANOLS FROM PLANT SOURCES | TECHNISCHE UNIVERSITÄT BERGAKADEMIE FREIBERG (DE) | 2022-06-16 | — | — | WO | disclosed |
| US-20220175000-A1 | WATER-SOLUBLE ADDITIVE COMPOSITION | RESEARCH INSTITUTE OF INNOVATIVE TECHNOLOGY FOR THE EARTH (JP) | 2022-06-09 | — | — | US | disclosed |
| CN-114452274-A | Application of plateau catechuic acid in preparing medicine for treating polycystic ovary syndrome | 佛山市第一人民医院 | 2022-05-10 | — | — | CN | disclosed |
| US-20220096463-A1 | LEVORPHANOL PRODRUGS AND PROCESSES FOR MAKING AND USING THEM | ALTER DOMUS (US) LLC | 2022-03-31 | — | — | US | disclosed |
| US-20220089544-A1 | DEXTRORPHAN PRODRUGS AND PROCESSES FOR MAKING AND USING THEM | ALTER DOMUS (US) LLC | 2022-03-24 | — | — | US | disclosed |
| EP-3950910-A1 | WATER-SOLUBLE ADDITIVE COMPOSITION | Sumitomo Bakelite Co.Ltd. (JP) | 2022-02-09 | — | — | EP | disclosed |
| US-11234975-B2 | Levorphanol prodrugs and processes for making and using them | KEMPHARM, INC. (US) | 2022-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12636402-B2 | Chitosan dressing for control of gastrointestinal bleeding | GLS, CDH1, ALPI | GAA 1133/4885KDM4E 537/4885TDP1 4487/4885 |
| US-12508171-B2 | Delivery systems for control of bleeding in transurethral prostatectomy | MUC1, BPHL, KLK3 | GAA 2257/4885KDM4E 1478/4885TDP1 2617/4885 |
| US-12590065-B2 | Levorphanol prodrugs and processes for making and using them | SLC16A3, SLC16A8, SLC16A1 | GAA 314/4885KDM4E 1294/4885TDP1 1657/4885 |
| US-11234975-B2 | Levorphanol prodrugs and processes for making and using them | OPRM1, OPRL1, OPRK1 | GAA 2834/4885KDM4E 2657/4885TDP1 1241/4885 |
| US-20220096463-A1 | LEVORPHANOL PRODRUGS AND PROCESSES FOR MAKING AND USING THEM | OPRM1, OPRL1, OPRK1 | GAA 2834/4885KDM4E 2657/4885TDP1 1241/4885 |
| US-12616771-B2 | Tissue adherent chitosan material that resists dissolution | CDH1, DSP, CD63 | GAA 2929/4885KDM4E 1411/4885TDP1 2986/4885 |
| US-20220089544-A1 | DEXTRORPHAN PRODRUGS AND PROCESSES FOR MAKING AND USING THEM | OGFR, OPRM1, CYP4F3 | GAA 2142/4885KDM4E 4435/4885TDP1 4008/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.